Pirin Inhibits FAS-Mediated Apoptosis to Support Colorectal Cancer Survival. 2024

Huanhuan Ma, and Muhammad Suleman, and Fengqiong Zhang, and Tingyan Cao, and Shixiong Wen, and Dachao Sun, and Lili Chen, and Bin Jiang, and Yue Wang, and Furong Lin, and Jinyang Wang, and Boan Li, and Qinxi Li
State Key Laboratory of Cellular Stress Biology, School of Life Sciences, Faculty of Medicine and Life Sciences, Xiamen University, Xiamen, 361102, China.

Resistance to immunotherapy in colorectal cancer (CRC) is associated with obstruction of FAS (Apo-1 or CD95)-dependent apoptosis, a hallmark of cancer. Here it is demonstrated that the upregulation of pirin (PIR) protein in colon cancers promotes tumorigenesis. Knockout or inhibition of PIR dramatically increases FAS expression, FAS-dependent apoptosis and attenuates colorectal tumor formation in mice. Specifically, NFκB2 is a direct transcriptional activator of FAS and robustly suppressed by PIR in dual mechanisms. One is the disruption of NFκB2 complex (p52-RELB) association with FAS promoter, the other is the inhibition of NIK-mediated NFκB2 activation and nuclear translocation, leading to the inability of active NFκB2 complex toward the transcription of FAS. Furthermore, PIR interacts with FAS and recruits it in cytosol, preventing its membrane translocation and assembling. Importantly, knockdown or knockout of PIR dramatically sensitizes cells to FAS mAb- or active CD8+ T cells-triggered cell death. Taken together, a PIR-NIK-NFκB2-FAS survival pathway is established, which plays a key role in supporting CRC survival.

UI MeSH Term Description Entries

Related Publications

Huanhuan Ma, and Muhammad Suleman, and Fengqiong Zhang, and Tingyan Cao, and Shixiong Wen, and Dachao Sun, and Lili Chen, and Bin Jiang, and Yue Wang, and Furong Lin, and Jinyang Wang, and Boan Li, and Qinxi Li
February 2015, Oncotarget,
Huanhuan Ma, and Muhammad Suleman, and Fengqiong Zhang, and Tingyan Cao, and Shixiong Wen, and Dachao Sun, and Lili Chen, and Bin Jiang, and Yue Wang, and Furong Lin, and Jinyang Wang, and Boan Li, and Qinxi Li
January 2017, Cell death & disease,
Huanhuan Ma, and Muhammad Suleman, and Fengqiong Zhang, and Tingyan Cao, and Shixiong Wen, and Dachao Sun, and Lili Chen, and Bin Jiang, and Yue Wang, and Furong Lin, and Jinyang Wang, and Boan Li, and Qinxi Li
January 2009, Experimental neurology,
Huanhuan Ma, and Muhammad Suleman, and Fengqiong Zhang, and Tingyan Cao, and Shixiong Wen, and Dachao Sun, and Lili Chen, and Bin Jiang, and Yue Wang, and Furong Lin, and Jinyang Wang, and Boan Li, and Qinxi Li
March 2002, Hepatology (Baltimore, Md.),
Huanhuan Ma, and Muhammad Suleman, and Fengqiong Zhang, and Tingyan Cao, and Shixiong Wen, and Dachao Sun, and Lili Chen, and Bin Jiang, and Yue Wang, and Furong Lin, and Jinyang Wang, and Boan Li, and Qinxi Li
April 1999, The EMBO journal,
Huanhuan Ma, and Muhammad Suleman, and Fengqiong Zhang, and Tingyan Cao, and Shixiong Wen, and Dachao Sun, and Lili Chen, and Bin Jiang, and Yue Wang, and Furong Lin, and Jinyang Wang, and Boan Li, and Qinxi Li
January 1996, Advances in experimental medicine and biology,
Huanhuan Ma, and Muhammad Suleman, and Fengqiong Zhang, and Tingyan Cao, and Shixiong Wen, and Dachao Sun, and Lili Chen, and Bin Jiang, and Yue Wang, and Furong Lin, and Jinyang Wang, and Boan Li, and Qinxi Li
June 2011, Investigative ophthalmology & visual science,
Huanhuan Ma, and Muhammad Suleman, and Fengqiong Zhang, and Tingyan Cao, and Shixiong Wen, and Dachao Sun, and Lili Chen, and Bin Jiang, and Yue Wang, and Furong Lin, and Jinyang Wang, and Boan Li, and Qinxi Li
June 1998, Cell death and differentiation,
Huanhuan Ma, and Muhammad Suleman, and Fengqiong Zhang, and Tingyan Cao, and Shixiong Wen, and Dachao Sun, and Lili Chen, and Bin Jiang, and Yue Wang, and Furong Lin, and Jinyang Wang, and Boan Li, and Qinxi Li
August 1999, Gynecologic oncology,
Huanhuan Ma, and Muhammad Suleman, and Fengqiong Zhang, and Tingyan Cao, and Shixiong Wen, and Dachao Sun, and Lili Chen, and Bin Jiang, and Yue Wang, and Furong Lin, and Jinyang Wang, and Boan Li, and Qinxi Li
January 1999, Nature medicine,
Copied contents to your clipboard!